Maine’s recreational marijuana industry continues to flourish, with $185,818,709 in sales recorded through the first nine months of 2025, despite prices reaching record lows. According to data from the state’s Office of Cannabis Policy, licensed adult-use marijuana retailers sold $21.2 million worth of products in September. That figure came from 425,302 transactions, at an average …
Category: News
Latest cannabis news covering legalization, legislation, court rulings, business developments, research, sales data, regulatory updates and policy changes across the U.S.
U.S. Congress: GOP Senator Calls for Federal Cannabis Legalization at DOJ Oversight Hearing
At a Senate Judiciary Committee hearing on oversight of the Department of Justice, Senator Thom Tillis (R-NC) pressed Attorney General Pam Bondi on the need to resolve marijuana’s ongoing conflict between state and federal law. “People have spoken,” Tillis said. “Many red states, even your home state and my home state, are trending towards legalizing …
Study: Cannabigerol May Protect Colon Health and Improve Metabolic Function Under High-Fat, High-Sugar Diet
A new study published in Biomedicine & Pharmacotherapy finds that cannabigerol (CBG), a non-psychoactive compound found in marijuana, may help counter the harmful effects of a high-fat, high-sugar diet on colon health and metabolic function. Researchers from the Medical University of Bialystok in Poland and the University of Mary Hardin-Baylor in Texas tested the compound …
National Survey: 62% of Adults Support Legalizing Cannabis, 31% Reported Using in the Past Six Months
A new national survey finds that nearly one in three adults have used cannabis in the past six months, and strong majorities support legalization, view dispensaries as beneficial to local economies, and believe marijuana offers significant health and wellness benefits. MRI-Simmons’ 2025 National Cannabis Study found that 31% of U.S. adults have consumed marijuana recently.
Study: CBD Reduces Neuroinflammation in Alzheimer’s Model by Targeting Key Immune Pathways
A new study published in eNeuro adds to the growing evidence that cannabidiol (CBD) may help slow Alzheimer’s disease progression by reducing inflammation in the brain. Researchers from Augusta University and the Georgia Institute of Cannabis Research tested CBD in male 5XFAD mice, a widely used Alzheimer’s model. The team focused on two key immune …
New York Marijuana Sales Hit Record $214.4 Million in August, $1.4 Billion Year-to-Date
New York’s legal marijuana market posted its strongest month yet in August, with dispensaries bringing in $214.4 million in sales, according to data presented today by the state’s Office of Cannabis Management. The new record represents a sharp increase from July’s $161.6 million and June’s $153.2 million. For comparison, sales in August 2024 totaled just …
New Jersey Cannabis Regulators Approve New Licenses, Delay Decision on Social Equity Excise Fee
New Jersey’s Cannabis Regulatory Commission approved a wide range of actions at its latest meeting on October 1, including issuing several new licenses and pushing back the deadline for decisions on the state’s Social Equity Excise Fee. The meeting opened with remarks from the chair highlighting the agency’s continued recognition as a national leader in …
New Mexico Marijuana Sales Surpass $428 Million So Far in 2025, Outpacing Last Year’s Pace
New Mexico’s marijuana industry recorded $44.3 million in sales during September, lifting the year-to-date total to just over $428 million. That figure puts the state ahead of last year’s pace, topping the $394.2 million sold during the first nine months of 2024 by nearly 10%. This is according to new data released today by the …
U.S. Congress: Legislation to Reschedule Cannabis Gains Bipartisan Support
Congressman Troy Carter (D-LA) has officially joined as a cosponsor of the Marijuana 1-to-3 Act of 2025, becoming the first Democrat to support the proposal and giving it bipartisan backing. The bill, introduced in August by Representative Gregory Steube (R-FL), would direct the Attorney General to move marijuana from Schedule I to Schedule III of …
Rhode Island Marijuana Sales Reach $89.4 Million Between January 1 and September 30
Rhode Island marijuana retailers recorded just under $9.92 million in sales for September, according to newly released data from the Cannabis Control Commission. The total includes $8.45 million from adult-use purchases and $1.47 million from medical marijuana sales.
Sponsored
